SCHEMBL6264609

SCHEMBL6264609

C/C=C(/CC)c1ccc(O)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 13/20 0.67
ESR2 Q92731 9/20 0.67
PTGS1 P23219 4/20 0.56
LMNA P02545 3/20 0.56
CYP1A2 P05177 3/20 0.56
CYP3A4 P08684 3/20 0.56
ADORA3 P0DMS8 3/20 0.56
CYP2D6 P10635 3/20 0.56
MAPT P10636 3/20 0.56
CYP2C9 P11712 3/20 0.56
ALOX15 P16050 3/20 0.56
CYP2C19 P33261 3/20 0.56
CHRM1 P11229 3/20 0.56
SLC6A2 P23975 3/20 0.56
MEN1 O00255 2/20 0.56
NR3C1 P04150 2/20 0.56
TP53 P04637 2/20 0.56
OPRD1 P41143 2/20 0.56
KMT2A Q03164 2/20 0.56
HIF1A Q16665 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10581272 1.00 ESR1 (0.67) ESR1ESR2PTGS1LMNACYP1A2
SCHEMBL10583351 0.82 HSD17B3 (0.55) ESR1ESR2PTGS1LMNACYP1A2
SCHEMBL12459964 0.82 HSD17B3 (0.55) ESR1ESR2PTGS1LMNACYP1A2
SCHEMBL10581682 0.82 ESR1 (0.62) ESR1ESR2PTGS1LMNACYP1A2
SCHEMBL19159318 0.81 ESR1 (0.45) ESR1ESR2PTGS1LMNAMAPT
SCHEMBL9113341 0.80 ESR1 (1.00) ESR1ESR2PTGS1LMNACYP1A2
SCHEMBL574346 0.80 ESR1 (1.00) ESR1ESR2PTGS1LMNACYP1A2
SCHEMBL23145325 0.79 HTT (0.44) ESR1ESR2PTGS1LMNACYP1A2
SCHEMBL9702762 0.79 ESR1 (0.50) ESR1ESR2PTGS1LMNACYP1A2
SCHEMBL2082470 0.79 ESR1 (0.44) ESR1ESR2PTGS1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1587906-A2 VESICANT TREATMENT WITH PHENYL-PHENYL TYPE VITAMIN D RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2005-10-26 EP disclosed
WO-2004063345-A2 VESICANT TREATMENT WITH PHENYL-PHENYL TYPE VITAMIN D RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2004-07-29 WO disclosed